Welcome to LookChem.com Sign In|Join Free
  • or
6-formylpyridine-2-carbothionic acid-S-3,4-dichlorophenyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

547742-07-4

Post Buying Request

547742-07-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

547742-07-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 547742-07-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,4,7,7,4 and 2 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 547742-07:
(8*5)+(7*4)+(6*7)+(5*7)+(4*4)+(3*2)+(2*0)+(1*7)=174
174 % 10 = 4
So 547742-07-4 is a valid CAS Registry Number.

547742-07-4Relevant academic research and scientific papers

Synthesis of 6-formyl-pyridine-2-carboxylate derivatives and their telomerase inhibitory activities

Jew, Sang-Sup,Park, Boon-Saeng,Lim, Doo-Yeon,Kim, Myoung Goo,Chung, In Kwon,Kim, Joo Hee,Hong, Chung Il,Kim, Joon-Kyum,Park, Hong-Jun,Lee, Jun-Hee,Park, Hyeung-Geun

, p. 609 - 612 (2003)

Twenty-one pyridine-2-carboxylate derivatives were prepared by the coupling of 6-formyl-2-carboxylic acid with the corresponding phenol, thiophenol, and aniline, substituted with various functional groups. Among them, the 3,4-dichlorothiophenol ester (9p) showed the highest in vitro telomerase inhibitory activity and quite significant in vivo tumor suppression activity.

2 - SUBSTITUTED HETEROCYCLIC COMPOUNDS AND ANTITUMOR COMPOSITION COMPRISING THE SAME

-

Page 9-10; 29, (2010/02/06)

The present invention relates with 2-substituted heterocyclic compounds and antitumor composition comprising the same. The compound according to the present invention exhibits superior effect as telomerase inhibitor based on new mechanism (terlomere-terlomerase) which can resolve the problems occurring at the time of using chemotherapeutics, i.e side effects and cross resistance between related mechanism on using chemotherapeutics. In addition, the antitumor composition comprising the compound of the present invention exhibits superior effect in inhibiting the growth of cancer cell.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 547742-07-4